CSRXP: HOUSE MARKUPS ADD TO UNPRECEDENTED MOMENTUM TO HOLD BIG PHARMA ACCOUNTABLE
Committee Leaders Put Forward Solutions to Lower Prescription Drug Prices for… Read More

Committee Leaders Put Forward Solutions to Lower Prescription Drug Prices for… Read More
Administration Proposal Would Increase Competition, Transparency and Value —… Read More
Speech Adds to Unprecedented Momentum for Action, Now Lawmakers Must Deliver… Read More
Lawmakers Must Build on Momentum For Action With Permanent Repeal of Rebate… Read More
Interchangeable Products Will Help Increase Prescription Drug Competition and… Read More
Unanimous, Bipartisan Passage of Bills Targeting Brand Name Drug Companies’… Read More
Campaign Looks Forward to Working with Administration and Congress to Crack… Read More
U.S. House Oversight & Reform Committee Report Shines Light on Branded… Read More
Pharmaceutical Companies Increase Prices on 32 Brand Name Drugs to Start July… Read More
New Report Reveals “Hidden Hand” Of Brand Name Drug Industry In case you… Read More
Pallone and Maloney Announce Joint Investigation into Massive Price Tag on… Read More
Lawmakers Must Advance Solutions to Lower Drug Prices Washington,… Read More